BIA
GILD icon

BMT Investment Advisors’s Gilead Sciences GILD Stock Holding History

BMT Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-31,365
Closed -$2.04M – 84
2019
Q1 		$2.04M Buy
31,365
+650
+2% +$43.2K 1.11% 52
2018
Q4 		$1.92M Buy
30,715
+918
+3% +$64.2K 1.22% 40
2018
Q3 		$2.3M Buy
29,797
+2,444
+9% +$185K 1.32% 30
2018
Q2 		$1.94M Buy
27,353
+896
+3% +$63.3K 1.24% 39
2018
Q1 		$2M Buy
26,457
+2,205
+9% +$175K 1.34% 27
2017
Q4 		$1.74M Buy
24,252
+5,640
+30% +$428K 1.26% 38
2017
Q3 		$1.51M Buy
+18,612
New +$1.42M 1.39% 30

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BMT Investment Advisors's GILD Position: Q2 2019 in Review

BMT Investment Advisors sold out of Gilead Sciences (GILD) in Q2 2019, closing a stake of 31,365 shares — an estimated $2.04M sold.

BMT Investment Advisors first reported a position in GILD in Q3 2017 and held it in 7 quarters. The position peaked at $2.3M in Q3 2018. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

  • BMT Investment Advisors reported no remaining Gilead Sciences position as of Q2 2019 after selling out during the quarter.
  • BMT Investment Advisors sold 31,365 Gilead Sciences shares in Q2 2019, an estimated $2.04M.
  • BMT Investment Advisors first reported a position in Gilead Sciences in Q3 2017 and held it in 7 quarters.
  • BMT Investment Advisors's Gilead Sciences position peaked at $2.3M in Q3 2018.
  • 1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on BMT Investment Advisors's 13F filing for Q2 2019, filed 15 Aug 2019.